Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director F Barry Bays sold 16,204 shares of the firm’s stock in a transaction dated Wednesday, April 26th. The stock was sold at an average price of $25.55, for a total value of $414,012.20. Following the sale, the director now owns 1,102,421 shares of the company’s stock, […]